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ABSTRACT  
Objectives: To analyse yearly rates of pelvic inflammatory disease (PID) and ectopic pregnancy (EP) 
diagnosed in hospital settings in Australia from 2009 to 2014.  
Methods: We calculated yearly PID and EP diagnosis rates in three states (Victoria, New South 
Wales, Queensland) for women aged 15 to 44 years using hospital admissions and emergency 
department (ED) attendance data, with population and live-birth denominators. We stratified PID 
diagnoses as chlamydial or gonorrheal-related (CT-or-NG-related), acute, unspecified and chronic and 
analysed variations by year, age and residential area using Poisson regression models.  
Results: For PID, the rate of all admissions in 2014 was 63.3 per 100,000 women (95% confidence 
interval CI 60.8 to 65.9) and of all presentations in EDs was 97.0 per 100,000 women (95%CI 93.9 to 
100.2).  Comparing 2014 with 2009: the rate of all PID admissions did not change, but the rate of all 
presentations in ED increased (adjusted incidence rate ratio, aIRR 1.34, 95%CI 1.24 to 1.45), and for 
admissions by PID category was higher for CT-or-NG-related PID (aIRR 1.73, 95%CI 1.31 to 2.28) 
and unspecified-PID (aIRR 1.09, 95%CI 1.00 to 1.19) and lower for chronic-PID (aIRR 0.84, 95%CI 
0.74 to 0.95). For EP, in 2014 the rate of all admissions was 17.4 (95% CI 16.9 to 17.9) per 1000 live 
births and of all ED presentations was 15.6 (95% CI 15.1 to 16.1). Comparing 2014 with 2009, rates 
of all EP-admissions (aIRR 1.06, 95%CI 1.04-1.08) and rates in ED (aIRR 1.24, 95%CI 1.18-1.31) 
were higher.  
Conclusions: PID and EP remain important causes of hospital admissions for female sexually 
transmitted infection associated complications.  Hospital EDs care for more PID cases than inpatient 
departments, particularly for young women. Updated primary care data are needed to better 
understand PID epidemiology and healthcare usage. 
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INTRODUCTION 
Chlamydia trachomatis and Neisseria gonorrhoeae can ascend to the upper genital tract and have 
serious health consequences for women, including pelvic inflammatory disease (PID), which can lead 
to ectopic pregnancy (EP), chronic pelvic pain or infertility1 2  that  maybe unrecognised until affected 
women try to conceive. These sequelae account for substantial health care costs3 and their prevention 
is an important reason for sexually transmissible infection (STI) control policies.4   
In many countries including Australia, PID and EP are not statutorily notifiable but datasets about 
diagnoses in hospitals provide information about rates over time. The gonorrhoea epidemics in many 
industrialised countries during the 1960s and 1970s were associated with increasing PID incidence 
followed by increasing EP incidence.5 From the 1980s to 2010, declining PID rates in hospital 
admissions and general practice were reported in several countries including Australia5-14 with some 
reports suggesting declines were influenced by STI control.12 However, in the 1980s and 1990s falls in 
PID and STIs were also attributed to sexual behaviour changes in response to the HIV epidemic.6  Stable 
or declining EP rates have been reported during the 1990s and 2000s in some countries,7-9 but increasing 
rates have also been reported.10  
In 2007 in Australia,  the hospital admission rate for PID was 89 per 100,000 population and EP was 
16 per 1000 live births, amongst women aged 15-39 years.8  Since then, chlamydia and gonorrhea 
diagnoses patterns have changed. Amongst women, age-standardised chlamydia diagnosis rates 
increased from 2007-2011, were stable to 2015 then increased in 2016.15 Although gonorrhoea occurs 
predominantly among men who have sex with men, notification rates in women more than doubled 
from 2007-2016, raising concerns about potential reproductive tract complications.15 The primary 
objective of this study was to analyse yearly rates of PID and EP diagnosed in Australian hospital 
settings.  A secondary objective was to examine associations between PID or EP diagnosis and 
characteristics of residential area.   
METHODS 
We undertook an ecological study using data of numbers of hospital admissions and emergency 
department (ED) attendances for PID and EP in the three most populous Australian states, New South 
Wales, Victoria and Queensland.  The study was approved by the Royal Australian College of 
General Practitioners National Research and Evaluation Ethics Committee (NREEC09.019). 
We obtained data from state Departments of Health from separate hospital admissions and ED 
attendances registers (supplementary table 1). We received non-identifiable, line-listed records for 15-
44-year-old female patients during 2009-2014.  Hospital admission datasets included data from all 
public (government-funded) and private hospitals. ED datasets included data for presentations to 
public hospitals with a designated ED. Data reporting from EDs was voluntary and clinicians assigned 
diagnosis codes, making ED data more variable than admissions data. ED attendances can result in 
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discharge or hospital admission, the latter also counted in admissions datasets, but, we could not 
merge these datasets owing to de-identified records and different data systems.  
Each patient record included a principal diagnosis for the main reason for care and ‘other’ diagnoses 
made, each coded using ICD10-AM or for some EDs, ICD9 or Systematized Nomenclature of 
Medicine. Data items included year, agegroup, residential postcode, and, principal diagnosis code on 
which a PID or EP diagnosis was assigned (table 1, supplementary table 2). Like other Australian 
studies,7 8 we excluded records with an ‘other’ PID or EP diagnosis because they might represent pre-
existing conditions. We categorised PID admissions further as chlamydial-or-gonorrhoeal-related 
(CT-or-NG-related PID), acute-PID, PID-unspecified, or, chronic-PID. As this analysis focussed on 
trends we only included ED records from hospitals contributing data in all years and if annual 
presentation numbers varied by <50%. 
Denominator data were obtained from the Australian Bureau of Statistics (supplementary table 1).  At 
postcode level these included estimated female residential population by year, age, remoteness, and 
index of relative socio-economic disadvantage (IRSD).16 Like another Australian study8 we obtained 
the number of live births by maternal age and year for our EP denominator. The three states 
comprised 1738 postcodes.  Postcodes were excluded (n=18) if the population was zero (e.g. company 
postcodes) or off-shore island/s; or, recoded to a neighbouring postcode (n=42) if IRSD was 
unavailable or the population for some agegroups was zero (e.g. remote postcodes). The remaining 
1678 postcodes were categorised for remoteness (metropolitan, inner-regional, outer-regional and/or 
remote using standard definitions) and deciles of increasing socio-economic disadvantage based on 
the IRSD.   
We prepared three datasets. The all-admissions and all-ED datasets included all hospital admissions or 
ED presentations with a principal PID or EP diagnosis, and population by postcode, year and agegroup. 
The non-admitted-ED dataset was a subset comprising PID or EP episodes discharged from EDs 
without admission.  
Statistical analysis 
We analysed datasets separately, using Stata 14 (StataCorp, College Station, Texas, USA). We 
calculated yearly PID and EP rates per 100,000 women using population denominators and EP rates per 
1,000 live births.  We examined variation in rates by year, agegroup, remoteness and socio-economic 
disadvantage of postcode using univariable and multivariable Poisson regression models with clustered 
sandwich estimator to account for intragroup correlation.17 We included year as a categorical variable 
to see whether rates differed from the reference category of 2009. We report incidence rate ratios (IRR) 
with 95% confidence intervals (95% CI). Where necessary, we used zero-inflated Poisson (ZIP) 
regression to account for large numbers of postcodes with no cases, and compared the fit to ordinary 
Poisson models using the Vuong test.18 Using likelihood ratio tests, we investigated interactions 
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between residential area and agegroup and reported them if statistically and clinically meaningful. We 
conducted a subgroup analysis of admission rates by PID category. Two sensitivity analyses were 
undertaken to examine robustness of our results. The first used linear splines to explore the rate of 
change in overall rates per two-year period. The second repeated our analysis of population rates, 
omitting postcodes recoded to neighbouring postcodes.  
RESULTS 
From 2009-2014 we recorded totals of 14,271 admissions and 20,522 ED presentations with a 
principal PID diagnosis, and 23,579 admissions and 19,382 ED presentations with a principal EP 
diagnosis, across 1,678 postcodes (table 1, supplementary table 2).  The median population of 15-44-
year-old women in study postcodes in 2009 was 946 (interquartile range 212-3254). Two-fifths (42%) 
of postcodes were metropolitan (representing 76% of the population), 29% in outer-regional/remote 
areas (7% of the population) and 41% of the population lived in more disadvantaged (five most 
disadvantaged IRSD deciles) areas.  
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Table 1 Number of hospital admissions and emergency department presentations for PID and EP, and, 
age breakdown of the population and live birth denominators, by year, 2009-2014 
  2009 2010 2011 2012 2013 2014 Overall 
  n (%) n (%) n (%) n (%) n (%) n (%) N (%)  
Pelvic inflammatory disease*        
Total admissions 2,141 2,314 2,510 2,429 2,502 2,375 14,271 (100) 
CT-or-NG-related-PID† 81 (3.8) 126 (5.4) 123 (4.9) 141 (5.8) 157 (6.3) 142 (6.0) 770 (5.4) 
Acute PID‡ 124 (5.8) 140 (6.1) 176 (7.0) 151 (6.2) 152 (6.1) 152 (6.4) 895 (6.3) 
Unspecified PID§ 1,379 (64.4) 1,513 (65.4) 1,674 (66.7) 1,614 (66.4) 1,613 (64.5) 1,592 (67.0) 9385 (65.8) 
Chronic PID ǁ 557 (26.0) 535 (23.1) 537 (21.4) 523 (21.5) 580 (23.2) 489 (20.6) 3221 (22.6) 
Total ED presentations 2566 2971 3438 3838 4067 3642 20522 (100) 
Admitted from ED 746 (29.1) 837 (28.2) 1,054 (30.7) 1,172 (30.5) 1,375 (33.8) 1,298 (35.6) 6482 (31.6) 
Not admitted from ED 1,820 (70.9) 2,134 (71.8) 2,384 (69.3) 2,666 (69.5) 2,692 (66.2) 2,344 (64.4) 14040 (68.4) 
Ectopic pregnancy¶        
Total admissions 3,870 3,768 3,981 3,841 4,072 4,047 23,579 (100) 
Total ED presentations 2,974 2,840 2,996 3,394 3,549 3,629 19382 (100) 
Admitted from ED 2,325 (78.2) 2,233 (78.6) 2,365 (78.9) 2,657 (78.3) 2,800 (78.9) 2,785 (76.7) 15165 (78.2) 
Not admitted from ED 649 (21.8) 607 (21.4) 631 (21.1) 737 (21.7) 749 (21.1) 844 (23.3) 4217 (21.8) 
Denominator/s         
Estimated residential population#  
(N) 
3,534,785 3,578,562 3,611,095 3,659,865 3,708,538 3,754,048  
15-24 years (%) 32.2 32.1 33.8 31.6 31.4 31.2  
25-34 years (%) 33.4 33.7 34.0 34.2 34.8 35.2  
35-44 years (%) 34.4 34.2 34.2 34.0 33.8 33.5  
Live births** (N) 234,821 235,805 233,193 239,145 237,205 232,553  
15-24 years (%) 18.0 17.6 17.0 16.9 16.3 15.2  
25-34 years (%) 58.9 59.0 59.9 60.4 60.9 60.6  
35-44 years (%) 23.1 23.4 23.1 22.7 22.8 22.1  
*PID, International Classification of Diseases (ICD10) codes N70.0, N70.1, N70.9, N71.0, N71.1, N71.9, N73.0, N73.1, N73.2, N73.3, 
N73.4, N73.5, N73.8, N73.9, (N74.4+A56.1), (N74.3+ +A54.2)  
†CT-or-NG-related PID, ICD-10 codes (chlamydial PID N74.4+A56.1) and (gonococcal PID N74.3+A54.2),  
‡Acute-PID, ICD-10 codes N70.0, N71.0, N73.0 
§ Unspecified-PID, ICD-10 codes N70.9, N71.9, N73.2, N73.5, N73.8, N73.9 
ǁ Chronic-PID, ICD-10 codes N70.1, N71.1, N73.1, N73.4 
¶ Ectopic pregnancy, ICD-10 codes O00.0, O00.1, O00.2, O00.8, O00.9 
# Estimated residential population for females aged 15-44 years in  1678 study postcodes 
** Live births, maternal age 15-44 years   
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Pelvic inflammatory disease 
Two-thirds (65.8%) of PID hospital admissions were unspecified-PID, the remainder were chronic-
PID (22.6%), acute-PID (6.3%), CT-related-PID (5.3%) and NG-related-PID (0.1%). Most (93.7%)  
PID in ED was unspecified-PID, the remainder were acute-PID (6.0%), chronic-PID (0.1%) and CT-
related-PID (0.2%). One third (32%) of PID in ED resulted in hospital admission (table 1).   
Figure 1A and supplementary table 3 show annual PID rates per 100,000 women.  The overall PID 
admission rate increased from 60.6 in 2009 to 69.5 in 2011 then decreased to 63.3 in 2014.  Between 
2009-2014, the overall PID rate in ED increased from 72.6 to 97.0.   
In multivariable analysis (table 2) comparing 2014 with 2009; the rate of all PID admissions did not 
change (adjusted IRR 1.05, 95%CI 0.98-1.12), but within PID categories (table 3) were higher for 
CT-or-NG-related-PID (aIRR 1.73, 95%CI 1.31-2.28) and unspecified-PID (aIRR 1.09, 95%CI 1.00-
1.19), similar for acute-PID and lower for chronic-PID (aIRR 0.84, 95% CI 0.74-0.95). PID admission 
rates were higher for women aged 15-24 than 35-44 years (aIRR 1.09, 95%CI 1.04-1.14) including 
CT-or-NG-related-PID (aIRR 11.68, 95%CI 8.60-15.85) and unspecified-PID.  Chronic-PID 
admission rates were highest for women 35-44 years. In EDs, overall PID rates were higher in 2014 
than 2009 (aIRR 1.34, 95%CI 1.24-1.45) including PID managed without admission, and, were more 
than twice as high for women aged 15-34 than 35-44 years. Higher PID rates were observed in more 
disadvantaged and non-metropolitan (regional or remote) than metropolitan areas. 
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Table 2: Factors associated with population rates of (A) PID and (B) ectopic pregnancy, and, (C) ectopic pregnancy rates per 1000 live births, 
2009-2014 
 
 
Univariable Multivariable  Univariable Multivariable  Univariable Multivariable 
 
IRR (95% CI) aIRR (95% CI) IRR (95% CI) aIRR (95% CI) IRR (95% CI) aIRR (95% CI) 
A: PID             
Age group in years             
15-24  1.11 (1.05-1.16) 1.09 (1.04-1.14) 2.78 (2.62-2.94) 2.72 (2.57-2.87) 3.12 (2.92-3.34) 3.02 (2.84-3.22) 
25-34 1.02 (0.97-1.07) 1.01 (0.96-1.06) 2.09 (1.98-2.21) 2.11 (2.00-2.23) 2.25 (2.11-2.40) 2.26 (2.12-2.41) 
35-44 1.0  1.0  1.0  1.0  1.0  1.0  
Area of residence             
Metropolitan 1.0  1.0  1.0  1.0  1.0  1.0  
Inner regional 1.23 (1.17-1.29) 1.12 (1.07-1.18) 1.63 (1.51-1.75) 1.46 (1.36-1.56) 1.72 (1.58-1.87) 1.53 (1.41-1.65) 
Outer regional/remote 1.75 (1.63-1.87) 1.57 (1.47-1.69) 2.28 (2.02-2.57) 2.08 (1.87-2.32) 2.26 (1.96-2.60) 2.06 (1.81-2.34) 
Socioeconomic status of area             
Deciles of increasing 
disadvantage 
1.06 (1.05-1.07) 1.05 (1.04-1.06) 1.09 (1.08-1.10) 1.07 (1.06-1.08) 1.09 (1.08-1.10) 1.08 (1.07-1.09) 
Year             
2009 1.0  1.0  1.0  1.0  1.0  1.0  
2010 1.07 (1.00-1.15) 1.07 (1.00-1.15) 1.13 (1.04-1.23) 1.13 (1.05-1.22) 1.13 (1.02-1.24) 1.14 (1.04-1.24) 
2011 1.14 (1.07-1.23) 1.14 (1.07-1.22) 1.32 (1.21-1.45) 1.32 (1.22-1.42) 1.30 (1.18-1.44) 1.29 (1.18-1.41) 
2012 1.09 (1.01-1.16) 1.09 (1.02-1.16) 1.42 (1.30-1.55) 1.41 (1.31-1.53) 1.39 (1.26-1.54) 1.40 (1.28-1.53) 
2013 1.12 (1.04-1.20) 1.12 (1.05-1.20) 1.48 (1.36-1.62) 1.50 (1.39-1.62) 1.37 (1.24-1.52) 1.40 (1.28-1.53) 
2014 1.04 (0.97-1.12) 1.05 (0.98-1.12) 1.33 (1.22-1.45) 1.34 (1.24-1.45) 1.22 (1.11-1.35) 1.22 (1.12-1.33) 
B: ECTOPIC PREGNANCY (population rates)           
Age group in years             
15-24  0.72 (0.69-0.76) 0.70 (0.67-0.74) 1.03 (0.97-1.10) 1.00 (0.95-1.06) 0.95 (0.82-1.09) 0.95 (0.83-1.09) 
25-34 2.05 (1.98-2.13) 2.04 (1.96-2.12) 2.33 (2.21-2.45) 2.32 (2.20-2.44) 2.10 (1.84-2.40) 2.08 (1.82-2.38) 
35-44 1.0  1.0  1.0  1.0  1.0  1.0  
Area of residence             
Metropolitan 1.0  1.0  1.0  1.0  1.0  1.0  
Inner regional 1.12 (1.06-1.19) 1.16 (1.10-1.22) 1.16 (1.08-1.24) 1.16 (1.09-1.23) 0.84 (0.69-1.03) 0.91 (0.75-1.11) 
Outer regional/remote 1.46 (1.35-1.59) 1.43 (1.32-1.55) 1.19 (1.09-1.31) 1.13 (1.04-1.24) 0.64 (0.45-0.92) 0.69 (0.49-0.96) 
 All admissions All emergency department Non-admitted emergency department 
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Socioeconomic status of area             
Deciles of increasing 
disadvantage 
1.03 (1.02-1.04) 1.03 (1.03-1.04) 1.05 (1.04-1.06) 1.05 (1.04-1.06) 1.01 (1.00-1.03) 1.02 (1.00-1.04) 
Year             
2009 1.0  1.0  1.0  1.0  1.0  1.0  
2010 0.97 (0.91-1.03) 0.97 (0.92-1.02) 0.96 (0.89-1.03) 0.95 (0.89-1.02) 0.93 (0.79-1.10) 0.94 (0.80-1.10) 
2011 1.01 (0.95-1.07) 1.01 (0.95-1.06) 0.98 (0.91-1.05) 0.97 (0.91-1.04) 0.92 (0.79-1.06) 0.92 (0.80-1.06) 
2012 0.96 (0.91-1.03) 0.96 (0.90-1.01) 1.12 (1.04-1.20) 1.09 (1.02-1.17) 1.08 (0.93-1.27) 1.07 (0.92-1.25) 
2013 1.01 (0.95-1.08) 1.00 (0.94-1.06) 1.14 (1.05-1.22) 1.12 (1.04-1.20) 1.08 (0.92-1.27) 1.08 (0.92-1.25) 
2014 1.00 (0.94-1.06) 0.97 (0.92-1.03) 1.14 (1.06-1.24) 1.12 (1.05-1.20) 1.23 (1.04-1.44) 1.17 (1.00-1.37) 
C: ECTOPIC PREGNANCY (rates among live 
births)* 
         
Age group in years             
15-24  0.89 (0.85-0.93) 0.89 (0.87-0.91) 1.27 (1.15-1.40) 1.27 (1.24-1.31) 1.23 (0.83-1.83) 1.24 (0.83-1.83) 
25-34 0.81 (0.77-0.85) 0.81 (0.80-0.83) 0.94 (0.84-1.05) 0.94 (0.92-0.95) 0.94 (0.62-1.42) 0.93 (0.62-1.40) 
35-44 1.0  1.0  1.0  1.0  1.0  1.0  
Year             
2009 1.0  1.0  1.0  1.0  1.0  1.0  
2010 0.97 (0.83-1.14) 0.97 (0.95-0.99) 0.95 (0.77-1.17) 0.95 (0.92-0.98) 0.93 (0.49-1.78) 0.93 (0.49-1.76) 
2011 1.04 (0.89-1.20) 1.04 (1.00-1.07) 1.01 (0.83-1.24) 1.02 (0.98-1.05) 0.98 (0.53-1.80) 0.98 (0.54-1.79) 
2012 0.97 (0.84-1.14) 0.98 (0.95-1.00) 1.12 (0.91-1.38) 1.13 (1.09-1.16) 1.12 (0.63-2.00) 1.12 (0.63-1.97) 
2013 1.04 (0.88-1.24) 1.04 (1.02-1.07) 1.18 (0.97-1.44) 1.19 (1.15-1.22) 1.14 (0.63-2.06) 1.15 (0.64-2.05) 
2014 1.06 (0.89-1.25) 1.06 (1.04-1.08) 1.23 (1.03-1.47) 1.24 (1.18-1.31) 1.31 (0.71-2.44) 1.32 (0.71-2.45) 
IRR, incidence rate ratio;  95%CI, 95% confidence interval; aIRR, adjusted incidence rate ratio 
*Level of socio-economic disadvantage and remoteness of area were not included as variables in the analysis of EP rates among live births because these denominator data were not available at 
postcode level.  
 
 
10 
 
Table 3 Factors associated with PID admissions, by PID category, 2009-2014  
 
CT-or-NG-related PID Acute-PID Unspecified-PID Chronic-PID  
aIRR (95% CI) aIRR (95% CI) aIRR (95% CI) aIRR (95% CI) 
Age group in years         
15-24  11.68 (8.60-15.85) 0.74 (0.62-0.89) 1.46 (1.38-1.55) 0.20 (0.18-0.23) 
25-34 2.95 (2.11-4.13) 0.93 (0.78-1.10) 1.18 (1.12-1.25) 0.69 (0.64-0.75) 
35-44 1.0  1.0  1.0  1.0  
Area of residence         
Metropolitan 1.0  1.0  1.0  1.0  
Inner regional 0.88 (0.71-1.08) 1.31 (1.09-1.58) 1.13 (1.06-1.20) 1.10 (1.00-1.22) 
Outer regional/remote 1.56 (1.24-1.96) 1.78 (1.43-2.22) 1.68 (1.54-1.83) 1.11 (0.97-1.27) 
Socioeconomic status of area         
Deciles of increasing disadvantage 1.08 (1.05-1.11) 1.06 (1.03-1.09) 1.06 (1.05-1.07) 1.01 (1.00-1.03) 
Year         
2009 1.0  1.0  1.0  1.0  
2010 1.56 (1.18-2.07) 1.08 (0.84-1.40) 1.09 (1.00-1.18) 0.96 (0.85-1.09) 
2011 1.52 (1.15-2.01) 1.36 (1.06-1.75) 1.19 (1.09-1.29) 0.94 (0.83-1.06) 
2012 1.72 (1.31-2.25) 1.18 (0.92-1.52) 1.12 (1.03-1.22) 0.92 (0.81-1.04) 
2013 1.89 (1.44-2.47) 1.17 (0.91-1.52) 1.12 (1.03-1.22) 1.00 (0.88-1.13) 
2014 1.73 (1.31-2.28) 1.15 (0.89-1.50) 1.09 (1.01-1.19) 0.83 (0.73-0.95) 
CT-or-NG-related-PID, Chlamydial or gonococcal PID ; aIRR, adjusted incidence rate ratio; 95%CI, 95% confidence interval  
 
Ectopic pregnancy 
The most frequent EP diagnoses codes were O00.1 tubal pregnancy (70% of admissions), and, O00.9 EP-
unspecified (83% of ED) and 78% of EP in ED resulted in hospital admission. Yearly population rates of 
EP are shown in Figure 1B and supplementary table 3 and EP rates among live births in figure 1C.  
Population rates:  The overall  EP hospital admission rate per 100,000 women in 2014 was 107.8 and did 
not differ from 2009 (Table 2).  Between 2009-2014, EP rates in ED increased overall (84.1 to 96.7) and, 
for women discharged without admission (18.4 to 22.5).  
In multivariable analysis (table 2), comparing 2014 with 2009, EP rates in hospital admissions did not 
change but were higher in EDs (aIRR 1.12, 95%CI 1.05-1.20). Admission and ED rates were highest for 
women aged 25-34 compared with 35-44 years and in more disadvantaged and non-metropolitan areas.  
Rates of EP discharged from ED without admission were higher in 2014 than 2009 (aIRR 1.17, 95%CI 
1.00-1.37) and lowest in outer-regional/remote areas (aIRR 0.69, 95%CI 0.49-0.96).   
Live birth rates: Overall EP rates per 1000 live births in 2014 were 17.4 in admissions, 15.6 in ED, and 
3.6 for ED but not admitted.  In multivariable analysis, EP admission rates (table 2) were higher in 2014 
than 2009 (aIRR 1.06, 95%CI 1.04-1.08) and highest for women 35-44 years.  In ED, EP rates were 
highest for women aged 15-24 years and in 2014 compared with 2009 (aIRR 1.24, 95%CI 1.18-1.3).  
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Sensitivity analyses 
Linear splines showed the rate of change for population rates did not alter during the study, and, the rate 
of change for ED-EP live birth rates during 2011-2012 was higher than for 2009-2010 (supplementary 
table 4).  Omission of postcodes recoded to neighbouring postcodes showed negligible change to results 
(data available on request).   
DISCUSSION 
This ecological study found that for reproductive age women, overall PID admission rates were similar 
between 2009 and 2014.  Within PID categories, admission rates increased for CT-or-NG-related-PID and 
unspecified-PID, but declined for chronic-PID.  PID rates in EDs increased and were 2.7 times higher 
among women aged 15-24 than 35-44 years. Age variability in overall PID admission rates was less 
pronounced. EP rates among live births were higher in 2014 compared with 2009 in admissions and EDs.  
Strengths and weaknesses 
Our study had two main strengths. First, inclusion of ED data provided new information about PID and 
EP diagnoses in Australia, and, like other studies7 8 included public and private hospital admissions for a 
complete picture of PID and EP admissions.  PID rates for women admitted from ED showed a similar 
pattern between the admissions and ED datasets. Second, undertaking our analysis at postcode level 
allowed exploration of the relationship between area characteristics and population rates. Large numbers 
of postcodes with no diagnoses were accommodated by the multivariable ZIP analysis for which our 
findings were consistent with ordinary Poisson models.  
An important study limitation is our PID rates included only women managed in hospital. Australian 
guidelines recommend inpatient management for severe PID and outpatient management for mild-
moderate PID.19  While admissions data can tell us about severe PID, most mild-moderate PID is 
managed in primary care,20 general practice being Australia’s mainstream primary care setting.  Primary 
care data are needed for a more complete picture of PID, but aren’t routinely available. Second, because 
ED data provision is voluntary, we consider our admission data more reliable than ED data. We 
minimised variability in ED rates by limiting our analysis to EDs contributing data for all study years and 
with high completeness. Third, clinical PID diagnosis has low sensitivity and specificity compared with 
laparoscopic visualisation.2 Absolute diagnosis rates might be inaccurate but, if diagnostic practices were 
unchanged these trends should be reliable.  Uterine, cervical motion or adnexal tenderness in sexually 
active women with pelvic pain are the mainstay of PID diagnosis2 and until non-invasive biomarkers for 
upper genital tract inflammation are widely available,2 large scale diagnostic changes that affect estimated 
rates are unanticipated.  However, current policies promote opportunistic chlamydia testing4 and could 
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contribute to identifying more STI-associated PID. Fourth, our birth denominator did not include all 
conceptions and EP rates could be influenced by other pregnancy outcomes (e.g. stillbirths, abortion) over 
time. We could not address this issue because data about all conceptions aren’t routinely available, but 
live birth denominators have been accepted previously.8 21  Finally, being an ecological study, we cannot 
make causal inferences about factors that might influence rates over time.  We show yearly age-adjusted 
rates, and our area measures allowed comparisons between more or less affluent or urban and non-urban 
areas.   
Comparison with other studies 
We found admission rates in 2009 per 100,000 of 61 for PID and 110 for EP among reproductive-aged 
women. An earlier Australian study (2001-2008) reported annual infertility admission rates for same-aged 
women of around 400 per 100,000.22 Our overall PID admission rates were similar between 2009-2014 
which is broadly consistent with a commissioned review presenting hospital discharge rates for 
inflammatory diseases of female pelvic organs (including any cause PID) during 1990-2014 across 
Europe, America and Australia, showing declining country specific rates to around 2007, that then 
appeared to plateau in several countries including Australia.23 This is the first Australian study to assess 
PID rates using routinely collected ED data. Our findings of increasing PID rates contrasts with a study in 
the United States of America that found falling PID rates (2002-2009) among adolescents attending 
EDs.14 For EP, stable or declining admission rates using live birth denominators have been reported in 
Australia and internationally until the 2000s, with increases in some groups.7 8 21 We found EP admission 
rates among live births in 2014 were 8% higher than for 2009.  We are unaware of other studies 
measuring EP trends in EDs.   
Interpretation of the findings  
This study provides some evidence that declines in PID observed in Australia7 8 and elsewhere8 might 
have ceased or even reversed. Several factors might contribute to this.  First, STI epidemiology and 
sexual behaviour  might be changing, and, PID is most common among young sexually active women.2 
Population-based data show increasing numbers of lifetime sex partners for young Australians, potentially 
increasing STI risk24 and surveillance data show  increasing chlamydia and  gonorrhoea rates among 
women that appear to reflect increased testing and transmission.15 Other Australian data show higher risks 
for PID hospitalisation following gonorrhea or chlamydia compared with no infection.25 Although we 
found increasing CT-related-PID rates and to a lesser extent NG, this might reflect increased testing or 
that clinicians are more likely to diagnose PID for women with lower abdominal symptoms and a positive 
test.  Second, increased screening and treatment of diagnosed infections renders more women susceptible 
to reinfection. Chlamydia reinfection substantially increases PID risk1 2 23 and is common, repeat 
13 
 
chlamydia diagnosis rates of 22%, in the year after treatment have been reported in Australia.26 Third, 
most PID was unspecified so other causes should be considered. Mycoplasma genitalium has been 
detected in 2.4% of Australian women attending primary care27 and is receiving attention worldwide as a 
PID pathogen with worrying levels of antimicrobial resistance.2 23 Bacterial vaginosis has been diagnosed 
in up to 12% of Australian women, and BV-associated microbes are often found in the upper genital tract 
of women with PID.2 23 PID can also develop after uterine instrumentation, although this risk is greatest if 
an STI is present.28  The extent these factors contribute to our findings is unknown and further research 
about PID causes is needed. 
Australian data for 1998-2003 have shown around 59,000 PID general practice encounters annually.20 
Factors restricting primary care access could also contribute to increased ED rates.  Timely access to 
Australian general practice is a concern particularly in non-metropolitan areas where there are ongoing 
workforce shortages29 that could contribute to higher STI rates15 thereby increasing PID risk.  Further, 
out-of-pocket expenses30  in primary care  might prompt women to attend ED instead for mild-moderate 
PID not requiring hospital admission. During the study period, average out-of-pocket costs increased by 
41%.31  
Increasing EP rates could reflect increased risk of extrauterine conception or increased detection of 
extrauterine pregnancy.  Risk factors for extrauterine conception include smoking, post-infection tubal 
damage (particularly chlamydia), assisted-reproductive-technologies and older maternal age.32 The extent 
these risks impact on EP rates is unknown, although, smoking rates in pregnancy have declined and 
maternal age has increased in Australia, where EP-related mortality is rare.33 34 Factors that increase EP 
diagnosis include more sensitive β-HCG tests to detect EP that might previously have resulted in 
undiagnosed tubal abortion, high-resolution-transvaginal ultrasound, early pregnancy units, and close 
monitoring of assisted reproduction outcomes. Our finding that a fifth of EP in ED were managed without 
admission is consistent with increased use of non-surgical (methotrexate) or conservative (wait and see) 
management34 in some areas.  
Implications for research, practice and policy 
Prevention of PID and its associated complications is a key goal of STI control, yet trends in these 
conditions are generally not routinely monitored.  The challenges in measuring PID and EP rates in this 
and other studies highlight the need for improved data sources and surveillance systems (reflecting 
hospital and primary care) that facilitate comparable measures over time. Australian policy identifies the 
need for interventions in primary care to enhance STI management, particularly partner notification and 
retesting.4 23 Further analyses of hospital and primary care data can support evaluation of enhanced STI 
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management impacts. Research is also needed to better understand the role of other infections in PID, 
and, develop non-invasive and objective methods that can improve PID diagnosis in any setting.  
In conclusion, we found increasing rates of PID and EP diagnosis in ED, and, EP hospital admissions.  
These results could represent changing sexual practices, increasing STI transmission and re-infections, 
changing healthcare usage or increased EP detection from improved diagnosis.  Without primary care 
data knowledge of PID epidemiology and healthcare use in Australia is incomplete. PID and EP remain 
important causes of hospital admission for STI-associated complications.  EDs provide care for many 
additional PID cases, particularly for young women warranting a strengthened focus on understanding 
drivers of these rates and on reducing risks of these sequelae. 
KEY MESSAGES 
• PID and EP remain important causes of hospital admissions for STI-associated complications 
among reproductive age women.  EDs care for many more PID cases, particularly for young 
women.  
• PID rates in EDs were substantially higher for younger than older women. PID hospital 
admission rates varied little by age.   
• Updated primary care data are needed to better understand PID epidemiology and healthcare 
usage, particularly given different patterns between hospital admissions and ED attendances.   
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A: Pelvic inflammatory disease - population denominator
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B. Ectopic pregnancy - population denominator
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C. Ectopic pregnancy - live birth denominator
